Navigation Links
AcelRx Pharmaceuticals Provides Clinical Trial Updates
Date:2/19/2013

nd commercial potential of other AcelRx Pharmaceuticals product candidates including ARX-04.  These forward-looking statements are based on AcelRx Pharmaceuticals' current expectations and inherently involve significant risks and uncertainties.  AcelRx Pharmaceuticals' actual results and the timing of events could differ materially from those anticipated in such forward-looking statements as a result of these risks and uncertainties, which include, without limitation, risks related to: the ability of AcelRx Pharmaceuticals to successfully complete the final clinical trial for ARX-01; the duration of time required to assess clinical trial results once the dosing of patients is completed; the success, cost and timing of all product development activities and clinical trials; the uncertain clinical development process, including the risk that clinical trials have an effective design; the final Phase 3 study enrolls a sufficient number of patients, or be completed on schedule, if at all; any delays or inability to obtain regulatory approval of its product candidates in the United States and Europe; its ability to obtain and maintain regulatory approvals of its product candidates; the market potential for its product candidates; the accuracy of AcelRx Pharmaceuticals' estimates regarding expenses, capital requirements and needs for financing; and other risks detailed in the "Risk Factors" and elsewhere in AcelRx Pharmaceuticals' U.S. Securities and Exchange Commission filings and reports, including its Current Report on Form 8-K filed with the SEC on December 7, 2012.  AcelRx Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in its expectations.


'/>"/>
SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. AcelRx Appoints Adrian Adams to Board of Directors as Chairman
2. AcelRx Pharmaceuticals Announces Pricing of Public Offering of Common Stock
3. AcelRx Pharmaceuticals Announces Proposed Public Offering Of Common Stock
4. AcelRx Pharmaceuticals to Present at the Piper Jaffray 24th Annual Healthcare Conference
5. AcelRx Announces Achievement of the Primary End-Point in Phase 3 Comparative Study Involving the Sufentanil NanoTab PCA System and Plans to Hold a Conference Call and Webcast Tomorrow to Discuss Top-Line Results
6. AcelRx Pharmaceuticals Reports Third Quarter 2012 Financial Results
7. AcelRx Pharmaceuticals Doses the First Patients in ARX-04 Phase 2 Clinical Study
8. AcelRx Pharmaceuticals to Hold Third Quarter 2012 Financial Results Conference Call and Webcast on November 6, 2012
9. AcelRx Pharmaceuticals Hires Mike A. Royal, M.D. as Chief, Clinical Affairs
10. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
11. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... 2015 Levi & Korsinsky is investigating the ... "Company") (NASDAQGS: BIIB) for possible violations of federal securities ... its officers and/or directors have violated Sections 10(b) and ... Friday, July 24, 2015, prior to the opening of ... results. Among other things, the Company lowered its prior ...
(Date:8/4/2015)... Aug. 4, 2015  MEI Pharma, Inc. (Nasdaq: MEIP ... novel therapies for cancer, announced today that Daniel P. ... at the 2015 Wedbush PacGrow Healthcare Conference on Tuesday, August ... Parker Meridien in New York . ... www.meipharma.com . A replay will be available approximately one ...
(Date:8/4/2015)... , Aug. 4, 2015 Research ... the addition of Jain PharmaBiotech,s new report ... and Companies" to their offering. ... drug delivery - an approach used to ... use as an alternative to oral,intravascular, subcutaneous ...
Breaking Medicine Technology:SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation of Biogen Inc. and Its Board of Directors in Connection with Possible Violations of Federal Securities Laws -- BIIB 2MEI Pharma to Present at Wedbush PacGrow Healthcare Conference 2Transdermal Drug Delivery Report 2015-2024 - Technologies, Markets, and Companies Analysis 2
... Feb. 2, 2012  On February 2, at the Late-Breaking Science ... of the TREVO Study ( T hrombectomy ... essel O cclusions in acute ischemic stroke). ... of clot-removing stent retriever technology. Sixty patients were enrolled by ...
... Feb. 2, 2012 On Jan. 23, IUE/CWA Local ... Davis Vision,s Newtown Square eyeglass manufacturing facility, went on ... international union (IUE/CWA). Although 115 employees are covered under ... According to company officials, each day, additional ...
Cached Medicine Technology:Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference 2Despite Employee Strike, Davis Vision Lab Continues to Fulfill Eyeglass Orders Without Service Interruption 2
(Date:8/4/2015)... New York, NY (PRWEB) , ... August 04, ... ... in a vegetarian capsule formula. Healthy Origins® Cognizin® is a trademark for ... a preferred base for a capsule for those applications which have more of ...
(Date:8/4/2015)... ... August 04, 2015 , ... It’s hard to look your ... Spa in Santa Barbara, CA is offering the solution by offering an underarm ... sweat and odor glands in the underarms. This simple and permanent solution usually ...
(Date:8/4/2015)... ... August 04, 2015 , ... Recent ... locations have shown a rise in binge drinking among certain populations ... and depression, are continuing to examine trends and evidence to help facilitate health ...
(Date:8/4/2015)... , ... August 04, 2015 , ... They say a ... understand certain health conditions, pictures and medical art can be essential. StayWell, a health ... , Krames Patient Education solutions have been used by physicians and other health ...
(Date:8/4/2015)... ... August 04, 2015 , ... SanusEO, the healthcare ... joins its executive leadership team as Senior Vice President of Sales and Marketing. ... and expanding global markets with a special emphasis on the healthcare industry. , ...
Breaking Medicine News(10 mins):Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 2Health News:Healthy Origins® Introduces Cognizin® Citicoline in a Vegetarian Capsule 3Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 2Health News:Simple, Non-Invasive, Permanent Solution To Stop Underarm Sweating in Santa Barbara 3Health News:DARA Responds To International Trends in Binge Drinking 2Health News:DARA Responds To International Trends in Binge Drinking 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3
... ... Ranneberger, to lead delegation of guests , ... Nairobi, Kenya (PRWEB) February 1, 2010 -- Canadian NGO, The Nancy Nielsen ... female Genital mutilation among the Masai, have organized a demonstration run/walk to protest FGM in ...
... ... http://www.kardeanutrition.com ) is pleased to announce that it has teamed with Dr Richard ... http://www.thecookingcardiologist.com/ ) to develop an integrated nutritional approach that advances cardiovascular health and ... ...
... ... pleased to announce a partnership with SDL, the leading provider of Global Information ... translation services in over 100 languages. , ... (PRWEB) February 1, 2010 -- Rapport International, ...
... (CI) rank their quality of life (QOL) equal to their ... 2010 issue of Otolaryngology Head and Neck Surgery ... that restores partial hearing to the deaf. It is surgically ... worn outside the ear. Unlike a hearing aid, it does ...
... is strongly associated with their parents, history of seeking dental ... Pediatrics, which has been released online, is the ... visits in a nationally represntative sample. "When parents ... to see the dentist," says Inyang Isong, MD, MPH, of ...
... , BOYNTON BEACH, Fla. , ... Boynton Beach, Florida , is the new network ... experiences of women and their many passions. Women from different locations, ... of ideas, advice, and support through various social media (blogs, facebook ...
Cached Medicine News:Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 2Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 3Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 4Health News:Over 3000 Participants Expected at “Zero Tolerance to FGM (Female Genital Mutilation) Run” 5Health News:Kardea Nutrition & The Cooking Cardiologist Join to Create Gourmet System for Heart Health 2Health News:Kardea Nutrition & The Cooking Cardiologist Join to Create Gourmet System for Heart Health 3Health News:Rapport International Announces Partnership with SDL 2Health News:Children with cochlear implants have quality of life equal to normal hearing peers 2Health News:Children more likely to visit the dentist if their parents do too 2Health News:Leslie Harris...Woman On The Move! 2Health News:Leslie Harris...Woman On The Move! 3
... offers a range of standard, enhanced ... delivers therapy to meet the needs ... in commercial and clinical effectiveness and ... the SleepStyle 200 series is the ...
The S8 Escape is the economy model of ResMeds S8 series. The S8 Escape is ideal for patients who want the convenience and portability of the S8 models but do not require the added comfort features of...
... is the premium CPAP device in ResMeds new ... line of flow generators are the smallest on ... to include an option of fully integrated heated ... for simplicity and convenience. Premium S8 models also ...
Low-taper wall construction guarantees error less than 1% absolute, 0.4 hematocrit, relative...
Medicine Products: